Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Waldencast ( (WALD) ) has shared an update.
On September 10, 2025, Waldencast plc announced that the FDA approved its Obagi® saypha® MagIQ™ injectable hyaluronic acid gel, marking the company’s entry into the U.S. HA dermal filler market under the Obagi Medical brand. This approval is a significant step in Waldencast’s strategy to become a leading dermatological megabrand, doubling Obagi Medical’s addressable market to $4.2 billion by 2029. The product, developed by Croma-Pharma GmbH, utilizes MACRO Core Technology for natural-looking results and is expected to launch in the U.S. in 2026, enhancing Waldencast’s market position and offering new opportunities for aesthetic professionals.
The most recent analyst rating on (WALD) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Waldencast stock, see the WALD Stock Forecast page.
Spark’s Take on WALD Stock
According to Spark, TipRanks’ AI Analyst, WALD is a Neutral.
Waldencast Acquisition’s overall stock score is primarily impacted by its financial performance and technical analysis. The company shows strong revenue growth and a solid balance sheet but struggles with profitability and cash flow. The technical indicators suggest a bearish trend, and the valuation is unattractive due to negative earnings. Despite some positive aspects from the earnings call, immediate financial and operational challenges weigh heavily on the stock’s outlook.
To see Spark’s full report on WALD stock, click here.
More about Waldencast
Waldencast plc is a global multi-brand beauty and wellness platform focused on developing, acquiring, and scaling high-growth, purpose-driven brands. The company aims to create a best-in-class beauty and wellness operating platform, leveraging its brand-led business model to ensure market responsiveness and agility. Waldencast’s portfolio includes Obagi Medical, known for its advanced skincare products addressing various skin concerns, and Milk Makeup.
Average Trading Volume: 270,990
Technical Sentiment Signal: Sell
Current Market Cap: $224.6M
See more data about WALD stock on TipRanks’ Stock Analysis page.